The review gives a short but comprehensive overview about selected biosimilars. Further, Adalimumab is analyzed in more detail, including a competitive field and the portfolio of methods required for analytical assessment. Markets not only in developed and highly regulated countries, but also in other regions are discussed.
Please find the full article here.
Tentamus Group GmbH was founded in 2011. Tentamus is a global product and safety group with a core presence in Europe, UK, Israel, China, Japan, India and the USA. Accredited and licensed Tentamus Group tests, audits and consults on all products involving the human body (food & feed, pharmaceuticals & medical, agrosciences, cosmetics, agriculture & environment and nutraceutical & supplements). Tentamus Group is represented in over 65 locations worldwide. More than 2,500 highly-trained staff members work in over 2.5 million square feet of laboratory and office spaces. For further information please visit www.tentamus.com.
Tentamus Group GmbH
An der Industriebahn 26
13088 Berlin
Telefon: +49 (30) 206038-230
Telefax: +49 (30) 206038-190
http://www.tentamus.com
Telefon: +43 189 059 7911
E-Mail: office@vela-labs.at
